Modulation of Hexadecyl-LPA-Mediated Activation of Mast Cells and Microglia by a Chemical Probe for LPA5-Reference-Cited by-同舟云学术

Modulation of Hexadecyl-LPA-Mediated Activation of Mast Cells and Microglia by a Chemical Probe for LPA5

Published:2016-03-07 Issue:9 Volume:17 Page:861-865
ISSN:1439-4227
Container-title:ChemBioChem
language:en
Short-container-title:ChemBioChem

Author:

Kozian Detlef H.¹,von Haeften Elisabeth²,Joho Sabrina¹,Czechtizky Werngard¹,Anumala Upendra R.³,Roux Pascale⁴,Dudda Angela¹,Evers Andreas¹,Nazare Marc³

Affiliation:

1. Sanofi-Aventis Deutschland GmbH; Industriepark Hoechst 65962 Frankfurt Germany

2. Merck Chemicals GmbH; Am Kronberger Hang 5 65824 Schwalbach Germany

3. Leibniz-Institut für Molekulare Pharmakologie FMP; Campus Berlin Buch 13125 Berlin Germany

4. Sanofi SA; 1541, avenue Marcel Merieux 69280 Marcy l'Etoile France

Publisher

Wiley

Subject

Organic Chemistry,Molecular Biology,Molecular Medicine,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cbic.201500559/fullpdf

Reference29 articles.

1. High-Throughput Analysis of Sphingosine 1-Phosphate, Sphinganine 1-Phosphate, and Lysophosphatidic Acid in Plasma Samples by Liquid Chromatography–Tandem Mass Spectrometry

2. LPA Receptors: Subtypes and Biological Actions

3. LPA5 Is Abundantly Expressed by Human Mast Cells and Important for Lysophosphatidic Acid Induced MIP-1β Release

4. Lysophosphatidic acid accelerates the development of human mast cells

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging roles of lysophosphatidic acid receptor subtype 5 (LPAR5) in inflammatory diseases and cancer;Pharmacology & Therapeutics;2023-05

2. Classes of Lipid Mediators and Their Effects on Vascular Inflammation in Atherosclerosis;International Journal of Molecular Sciences;2023-01-13

3. Isoquinolone derivatives as lysophosphatidic acid receptor 5 (LPA5) antagonists: Investigation of structure-activity relationships, ADME properties and analgesic effects;European Journal of Medicinal Chemistry;2022-12

4. An LPAR5-antagonist that reduces nociception and increases pruriception;Frontiers in Pain Research;2022-07-26

5. Lysophosphatidic Acid Receptor 5 (LPA5) Knockout Ameliorates the Neuroinflammatory Response In Vivo and Modifies the Inflammatory and Metabolic Landscape of Primary Microglia In Vitro;Cells;2022-03-22